Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic (2021)
- Authors:
- USP affiliated authors: CARRARA, HELIO HUMBERTO ANGOTTI - FMRP ; ANDRADE, JURANDYR MOREIRA DE - FMRP ; REIS, FRANCISCO JOSÉ CÂNDIDO DOS - FMRP ; BORBA, JÉSSICA MARIA CAMARGO - FMRP ; RODRIGUES, TAMARA CRISTINA GOMES FERRAZ - FMRP
- Unidade: FMRP
- DOI: 10.1158/1538-7445.SABCS20-PS13-30
- Subjects: NEOPLASIAS MAMÁRIAS; TERAPÊUTICA MÉDICA; COVID-19; RESULTADO DE TRATAMENTO
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2021
- Source:
- Título: Cancer Research
- ISSN: 0008-5472
- Volume/Número/Paginação/Ano: v. 81, n. 4, suppl., res. PS13-30, 2021
- Conference titles: San Antonio Breast Cancer Virtual Symposium
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PIMENTEL, Franklin Fernandes et al. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30. Acesso em: 29 dez. 2025. , 2021 -
APA
Pimentel, F. F., Borba, J. M. C., Rodrigues, T. C. G. F., Peruchi, K. P. I., Carrara, H. H. A., Andrade, J. M. de, & Reis, F. J. C. dos. (2021). Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic. Cancer Research. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1158/1538-7445.SABCS20-PS13-30 -
NLM
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM de, Reis FJC dos. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2025 dez. 29 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30 -
Vancouver
Pimentel FF, Borba JMC, Rodrigues TCGF, Peruchi KPI, Carrara HHA, Andrade JM de, Reis FJC dos. Evaluation of factors related to efficacy and safety of neo/adjuvant chemotherapy for breast cancer as a brief estimate of the impact of COVID-19 pandemic [Internet]. Cancer Research. 2021 ; 81( 4):[citado 2025 dez. 29 ] Available from: https://doi.org/10.1158/1538-7445.SABCS20-PS13-30 - Chemotherapy prescriptions and emergency medical care utilization by patients in neo/adjuvant breast cancer treatment during COVID-19 pandemic: patterns in a Brazilian university hospital
- Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients
- Neutropenia febril em pacientes com câncer de mama submetidas à quimioterapia: experiência de 12 anos
- Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast
- Idade como fator independente de prognóstico no câncer de mama
- Estimation of clinical benefit and economic burden for using a commercial 70-gene signature test for Brazilian breast cancer patients in the public health system
- Current breast cancer screening scenario in Brazil. [Editorial]
- Avaliação termográfica das pacientes submetidas a quimioterapia neoadjuvante
- Basal levels of DNA damage detected by micronuclei and comet assays in untreated breast cancer patients and healthy women
- Microinvasive carcinoma of the cervix: analysis of prognostic factors
Informações sobre o DOI: 10.1158/1538-7445.SABCS20-PS13-30 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003202573.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
